ASX Increases FY27 Investment Guidance as Technology Modernisation and ASIC Response Accelerate
ASX Limited (ASX: ASX) has released updated FY27 financial guidance, outlining materially higher investment spending as the exchange operator accelerates technology modernisation, regulatory remediation programs and customer-focused growth initiatives. The Company expects FY27 total expense growth of between 18% and 21%, while operating expense growth excluding depreciation and amortisation is forecast between 13% and 16% relative to FY26 levels.
ASX also lifted FY27 capital expenditure guidance to between AU$180 million and AU$200 million, up from previous guidance of AU$160 million to AU$180 million, with FY28 capex expected between AU$170 million and AU$190 million. Management stated the increase reflects technology cost inflation, expanded remediation programs linked to the ASIC Inquiry and investment in customer-driven innovation initiatives, including tokenisation opportunities and enhanced derivatives offerings.
The exchange operator confirmed its dividend policy remains unchanged at a 75%–85% payout ratio of underlying NPAT, although payouts are expected to remain at the lower end of the range for at least the next two dividends. ASX also disclosed the sale of its 49% interest in Sympli for a nominal amount, resulting in an estimated after-tax loss of approximately AU$12 million in FY26.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
ASX Increases FY27 Investment Guidance as Technology Modernisation and ASIC Response Accelerate
ASX Limited (ASX: ASX) has released updated FY27 financial guidance, outlining materially higher investment spending as the exchange operator accelerates technology modernisation, regulatory remediation programs and customer-focused growth initiatives. The Company expects FY27 total expense growth of between 18% and 21%, while operating expense growth excluding depreciation and amortisation is forecast between 13% and 16% relative to FY26 levels.
ASX also lifted FY27 capital expenditure guidance to between AU$180 million and AU$200 million, up from previous guidance of AU$160 million to AU$180 million, with FY28 capex expected between AU$170 million and AU$190 million. Management stated the increase reflects technology cost inflation, expanded remediation programs linked to the ASIC Inquiry and investment in customer-driven innovation initiatives, including tokenisation opportunities and enhanced derivatives offerings.
The exchange operator confirmed its dividend policy remains unchanged at a 75%–85% payout ratio of underlying NPAT, although payouts are expected to remain at the lower end of the range for at least the next two dividends. ASX also disclosed the sale of its 49% interest in Sympli for a nominal amount, resulting in an estimated after-tax loss of approximately AU$12 million in FY26.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au